Home LiteratureArticle Details
PMID: 12414935 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.

Journal of virology ·Vol. 76 ·No. 23 ·2002-12-00 ·Pages 11931-42

Krempl C, Murphy BR, Collins PL

Abstract

The genome of human respiratory syncytial virus (RSV) encodes 10 mRNAs and 11 proteins in the order 3'-NS1-NS2-N-P-M-SH-G-F-M2-1/M2-2-L-5'. The G and F glycoproteins are the major RSV neutralization and protective antigens. It seems likely that a high level of expression of G and F would be desirable for a live RSV vaccine. For mononegaviruses, the gene order is a major factor controlling the level of mRNA and protein expression due to the polar gradient of sequential transcription. In order to increase the expression of G and F, recombinant RSVs based on strain A2 were constructed in which the G or F gene was shifted from the sixth or seventh position (in a genome lacking the SH gene), respectively, to the first position (rRSV-G1/DeltaSH and rRSV-F1/DeltaSH, respectively). Another virus was made in which G and F were shifted together to the first and second positions, respectively (rRSV-G1F2/DeltaSH). Shifting one or two genes to the promoter-proximal position resulted in increased mRNA and protein expression of the shifted genes, with G and F expression increased up to 2.4-and 7.8-fold, respectively, at the mRNA level and approximately 2.5-fold at the protein level, compared to the parental virus. Interestingly, the transcription of downstream genes was not greatly affected even though shifting G or F, or G and F together, had the consequence of moving the block of genes NS1-NS2-N-P-M-(G) one or two positions further from the promoter. The efficiency of replication of the gene shift viruses in vitro was increased up to 10-fold. However, their efficiency of replication in the lower respiratory tracts of mice was statistically indistinguishable from that of the parental virus. In the upper respiratory tract, replication was slightly reduced on some days for viruses in which G was in the first position. The magnitude of the G-specific antibody response to the gene shift viruses was similar to that to the parental virus, whereas the F-specific response was increased up to fourfold, although this was not reflected in an increase of the neutralizing activity. Thus, shifting the G and F genes to the promoter-proximal position increased virus replication in vitro, had little effect on replication in the mouse, and increased the antigen-specific immunogenicity of the virus beyond that of parental RSV.

MeSH Terms
Animals Antibodies, Viral/blood Base Sequence Cell Line DNA, Viral/genetics Gene Expression Genes, Viral Genome, Viral Humans Mice Mice, Inbred BALB C Molecular Sequence Data Promoter Regions, Genetic RNA, Messenger/genetics,metabolism RNA, Viral/genetics,metabolism Recombination, Genetic Respiratory Syncytial Virus, Human/genetics,immunology,pathogenicity,physiology Viral Proteins/genetics Virus Replication/genetics
Chemicals
Antibodies, Viral DNA, Viral RNA, Messenger RNA, Viral Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Krempl Christine
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-8007, USA.
Murphy Brian R
Collins Peter L
References (41)
41 references, click to expand
  1. Bronchiolitis-associated hospitalizations among US children, 1980-1996.
    JAMA. 1999 Oct 20;282(15):1440-6 PMID: 10535434
  2. Sendai virus gene expression in lytically and persistently infected cells.
    Virology. 1990 Jul;177(1):131-40 PMID: 1693801
  3. Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.
    J Virol. 2000 Sep;74(17):7895-902 PMID: 10933697
  4. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
    Vaccine. 1990 Oct;8(5):497-502 PMID: 2251875
  5. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.
    J Virol. 1991 Mar;65(3):1634-7 PMID: 1995956
  6. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
    J Virol. 1992 Feb;66(2):1277-81 PMID: 1731105
  7. Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).
    J Virol. 1992 Nov;66(11):6813-8 PMID: 1404620
  8. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.
    J Virol. 1995 Apr;69(4):2412-9 PMID: 7884888
  9. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
    Virology. 1995 Jun 20;210(1):202-5 PMID: 7793072
  10. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.
    J Virol. 1995 Sep;69(9):5677-86 PMID: 7637014
  11. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11563-7 PMID: 8524804
  12. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):81-5 PMID: 8552680
  13. A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase.
    Genome Res. 1995 Nov;5(4):404-7 PMID: 8750200
  14. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate.
    Virology. 1996 Nov 15;225(2):419-22 PMID: 8918930
  15. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
    J Infect Dis. 1997 Nov;176(5):1215-24 PMID: 9359721
  16. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.
    J Virol. 1997 Dec;71(12):8973-82 PMID: 9371553
  17. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
    Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13961-6 PMID: 9391135
  18. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    J Infect Dis. 1997 Dec;176(6):1428-36 PMID: 9395351
  19. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription.
    J Virol. 1998 Jan;72(1):520-6 PMID: 9420254
  20. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.
    J Virol. 1998 Feb;72(2):1452-61 PMID: 9445048
  21. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3501-6 PMID: 9520395
  22. Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.
    J Virol. 1998 May;72(5):4467-71 PMID: 9557743
  23. Respiratory syncytial virus vaccines.
    Clin Microbiol Rev. 1998 Jul;11(3):430-9 PMID: 9665976
  24. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes.
    Virology. 1998 Aug 1;247(2):232-9 PMID: 9705916
  25. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.
    J Virol. 1999 Apr;73(4):3438-42 PMID: 10074199
  26. Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.
    J Virol. 1999 Jun;73(6):4705-12 PMID: 10233930
  27. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.
    J Virol. 1999 Jul;73(7):5852-64 PMID: 10364337
  28. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11259-64 PMID: 10500164
  29. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response.
    J Virol. 2000 Sep;74(18):8234-42 PMID: 10954520
  30. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.
    J Virol. 2000 Oct;74(19):9317-21 PMID: 10982380
  31. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.
    J Infect Dis. 2000 Nov;182(5):1331-42 PMID: 11010838
  32. Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo.
    J Virol. 2000 Dec;74(23):11017-26 PMID: 11069997
  33. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells.
    J Virol. 2002 May;76(9):4287-93 PMID: 11932394
  34. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.
    Am J Epidemiol. 1966 Mar;83(2):299-313 PMID: 5933417
  35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  36. Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells.
    Biochemistry. 1976 Apr 20;15(8):1663-7 PMID: 178352
  37. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription.
    Cell. 1981 Feb;23(2):477-84 PMID: 6258804
  38. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.
    Infect Immun. 1982 Jul;37(1):397-400 PMID: 7107009
  39. Altered transcription of a defective measles virus genome derived from a diseased human brain.
    EMBO J. 1987 Mar;6(3):681-8 PMID: 3582370
  40. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.
    J Virol. 1989 Jul;63(7):2941-50 PMID: 2470922
  41. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.
    Adv Virus Res. 1999;54:423-51 PMID: 10547682
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2002-12-00
Pages
11931-42
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC136893
Subset
IM
Grants
NIAID NIH HHS · AI-00087 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com